Applied Therapeutics (APLT) PT Lowered to $1.50 at RBC Capital Following FDA's Warning Letter
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams lowered the price target on Applied Therapeutics (NASDAQ: APLT) to $1.50 (from $4.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
